Status:
COMPLETED
Diabetes Risk Communication Tool Evaluation
Lead Sponsor:
National University of Singapore
Collaborating Sponsors:
National Medical Research Council (NMRC), Singapore
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
30-60 years
Phase:
NA
Brief Summary
Prevention for Type 2 Diabetes (T2D)has been vast but with limited success. While Singaporeans have high knowledge about T2D, its symptoms, and risk factors, healthy practices are still sub-optimal. U...
Eligibility Criteria
Inclusion
- Aged 30-60 years;
- Singapore citizen, or permanent resident
- Able to read and understand English,
- Have had a health screening with blood pressure, triglycerides, and HbA1C done within the last 3 months
- At least one risk factor for Type 2 Diabetes (BMI ≥ 23 kg/m2, blood pressure ≥130/85 mmHg or receiving therapy for hypertension, triglycerides ≥1.7mmol/L or HbA1c ≥5.7%)
Exclusion
- \- Diagnosis of any event of cardiovascular disease, kidney issues, or type 2 diabetes
Key Trial Info
Start Date :
June 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 7 2023
Estimated Enrollment :
460 Patients enrolled
Trial Details
Trial ID
NCT05427890
Start Date
June 20 2022
End Date
August 7 2023
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University of Singapore
Singapore, Singapore